Anagrelide: A Review of its Use in the Management of Essential Thrombocythaemia

Author： Wagstaff Antona J.   Keating Gillian M.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.1, 2006-01, pp. : 111-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anagrelide: a decade of clinical experience with its use for the treatment of primary thrombocythaemia

By Petrides Petro E  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 8, 2004-08 ,pp. : 1781-1798

Informa Healthcare

Access to resources Recommend Favorite

Anagrelide is an effective platelet-lowering agent, but its role in the treatment of essential thrombocythaemia has yet to be fully determined

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 11, 2006-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Anagrelide/hydroxycarbamide: Essential thrombocythaemia transformation to AML or MDS: 17 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1334, 2011-01 ,pp. : 8-9

Adis International

Access to resources Recommend Favorite

Moexipril: A Review of its Use in the Management of Essential Hypertension

By Brogden R.N.   Wiseman L.R.  

Drugs, Vol. 55, Iss. 6, 1998-06 ,pp. : 845-860

Adis International

Access to resources Recommend Favorite

Polycythaemia Vera and Essential Thrombocythaemia in the Elderly: Epidemiology, Management and Outcomes

By van Genderen P.J.J.   Troost M.M.  

Drugs & Aging, Vol. 17, Iss. 2, 2000-08 ,pp. : 107-119

Adis International

Access to resources Recommend Favorite